576 Federal Register / Vol. 76, No. 3 / Wednesday, January 5, 2011 / Notices 

Dated: December 28, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–33239 Filed 1–4–11; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of a meeting of the 

President’s Cancer Panel. 

The meeting will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

Name of Committee: President’s Cancer 

Panel. 

Date: February 1, 2011. 

Time: 8 a.m. to 4 p.m. 

Agenda: The Future of Cancer Research: 

Accelerating Scientific Innovation. 

Place: Grand Hyatt Atlanta, 3300 Peachtree 

Road, NE., Atlanta, GA 30305. 

Contact Person: Abby B. Sandler, PhD, 

Executive Secretary, Chief, Institute Review 

Office, Office of the Director, 6116 Executive 

Blvd., Suite 220, MSC 8349, National Cancer 

Institute, NIH, Bethesda, MD 20892–8349, 

(301) 451–9399, sandlera@mail.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

Information is also available on the 

Institute’s/Center’s home page: 

deainfo.nci.nih.gov/advisory/pcp/pcp.htm, 

where an agenda and any additional 

information for the meeting will be posted 

when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: December 28, 2010. 

Anna P. Snouffer, 

Deputy Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–33291 Filed 1–4–11; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications 

and/or contract proposals and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the grant 

applications and/or contract proposals, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; SPORE in 

Mesothelioma, Lung, Breast and Ovarian 

Cancers. 

Date: February 2–3, 2011. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Wlodek Lopaczynski, 

M.D., PhD, Scientific Review Officer, 

Research Programs Review Branch, Division 

of Extramural Activities, National Cancer 

Institute, 6116 Executive Blvd., Room 8131, 

Bethesda, MD 20892, 301–594–1402, 

lopacw@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; 

Development of Molecular Diagnostics Assay 

to Detect Basal-like Breast Cancer. 

Date: February 15, 2011. 

Time: 12 p.m. to 5 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, 6116 

Executive Boulevard, Room 703, Rockville, 

MD 20852, (Telephone Conference Call). 

Contact Person: Lalita D. Palekar, PhD, 

Scientific Review Officer, Special Review 

and Logistics Branch, Division of Extramural 

Activities, National Cancer Institute, 6116 

Executive Boulevard, Room 7141, Bethesda, 

MD 20892, 301–496–7575, 

palekarl@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; Systems for 

Automated Storage, Analysis, and Reporting 

of Objective Behavioral Exposures. 

Date: February 16–17, 2011. 

Time: 8:30 a.m. to 11 a.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: Legacy Hotel and Meeting Center, 

1775 Rockville Pike, Rockville, MD 20852. 

Contact Person: Ellen K Schwartz, E.D.D., 

M.B.A., Scientific Review Officer, Special 

Review & Logistics Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 6116 Executive Boulevard, 

Room 8055B, Bethesda, MD 20892–8329, 

301–594–1215, schwarel@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; 

Collaborative Research in Integrative Cancer 

Biology and the Tumor Microenvironment. 

Date: February 16, 2011. 

Time: 1 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6116 

Executive Boulevard, Room 8055A, 

Rockville, MD 20852, (Telephone Conference 

Call) 

Contact Person: Zhiqiang Zou, M.D., PhD, 

Scientific Review Officer, National Cancer 

Institute, National Institutes of Health, 6116 

Executive Blvd., Room 8055A, MSC 8329, 

Bethesda, MD 20852, zouzhiq@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; 

Smartphone Applications for Cancer 

Prevention and Control. 

Date: February 17, 2011. 

Time: 1 p.m. to 3 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: Legacy Hotel and Meeting Center, 

1775 Rockville Pike, Rockville, MD 20852. 

Contact Person: Ellen K Schwartz, E.D.D., 

M.B.A., Scientific Review Officer, Special 

Review & Logistics Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 6116 Executive Boulevard, 

Room 8055B, Bethesda, MD 20892–8329, 

301–594–1215, schwarel@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; 

Nanotechnology Sensing Platforms. 

Date: March 2, 2011. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: Hilton Washington/Rockville, 1750 

Rockville Pike, Rockville, MD 20852. 

Contact Person: Savvas C Makrides, PhD, 

Scientific Review Officer, Special Review 

and Logistics Branch, Division of Extramural 

Activities, National Cancer Institute, NIH, 

6116 Executive Blvd., Rm 8050a, Bethesda, 

MD 20892, 301–496–7421, 

makridessc@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; Innovative 

Technology Development. 

Date: March 2–3, 2011. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Legacy Hotel and Meeting Center, 

1775 Rockville Pike, Rockville, MD 20852. 

Contact Person: Jeffrey E. DeClue, PhD, 

Scientific Review Officer, Special Review 

and Logistics Branch, Division of Extramural 

Activities, National Cancer Institute, NIH, 

6116 Executive Boulevard, Room 8059, 

Bethesda, MD 20892–8329, 301–496–7904, 

decluej@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; 


jlentini on DSKJ8SOYB1PROD with NOTICES
Federal Register / Vol. 76, No. 3 / Wednesday, January 5, 2011 / Notices 577 

Nanotechnology Therapeutics and 

Theranostics. 

Date: March 3, 2011. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: Hilton Washington/Rockville, 1750 

Rockville Pike, Rockville, MD 20852. 

Contact Person: Savvas C Makrides, PhD, 

Scientific Review Officer, Special Review 

and Logistics Branch, Division of Extramural 

Activities, National Cancer Institute, NIH, 

6116 Executive Blvd., Rm 8050a, Bethesda, 

MD 20892, 301–496–7421, 

makridessc@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; 

Development of Blood-based Methods for the 

Detection of Cancer Recurrence in PostTherapy Breast Cancer Patients. 

Date: March 3, 2011. 

Time: 12 p.m. to 5 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, 6116 

Executive Boulevard, Room 703, Rockville, 

MD 20852, (Telephone Conference Call) 

Contact Person: Lalita D. Palekar, PhD, 

Scientific Review Officer, Special Review 

and Logistics Branch, Division of Extramural 

Activities, National Cancer Institute, 6116 

Executive Boulevard, Room 7141, Bethesda, 

MD 20892, 301–496–7575, 

palekarl@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; High Level 

Programming Language to Expedite 

Development of User Interfaces. 

Date: March 8, 2011. 

Time: 12 p.m. to 3 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, 6116 

Executive Boulevard, Room 607, Rockville, 

MD 20852, (Telephone Conference Call) 

Contact Person: Marvin L. Salin, PhD, 

Scientific Review Officer, Special Review 

and Logistics Branch, Division of Extramural 

Activities, National Cancer Institute, NIH, 

6116 Executive Boulevard, Room 7073, 

Bethesda, MD 20892–8329, 301–496–0694, 

msalin@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; NonCoding RNAs and Cancer. 

Date: March 10, 2011. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: Legacy Hotel and Meeting Center, 

1775 Rockville Pike, Rockville, MD 20852. 

Contact Person: Thomas M Vollberg, PhD, 

Scientific Review Officer, Special Review 

and Logistics Branch, Division of Extramural 

Activities, National Cancer Institute, 6116 

Executive Boulevard, Room 7142, Bethesda, 

MD 20892, 301–594–9582, 

vollbert@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; Health 

Information Technology to Facilitate PatientCentered Communication in Cancer Related 

Care. 

Date: March 10, 2011. 

Time: 12 p.m. to 3 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, 6116 

Executive Boulevard, Room 607, Rockville, 

MD 20852, (Telephone Conference Call) 

Contact Person: Marvin L. Salin, PhD, 

Scientific Review Officer, Special Review 

and Logistics Branch, Division of Extramural 

Activities, National Cancer Institute, NIH, 

6116 Executive Boulevard, Room 7073, 

Bethesda, MD 20892–8329, 301–496–0694, 

msalin@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; MultiCenter Clinical Trials. 

Date: March 14, 2011. 

Time: 2 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6116 

Executive Boulevard, Room 8103, Rockville, 

MD 20852, (Telephone Conference Call) 

Contact Person: Timothy C. Meeker, M.D., 

PhD, Scientific Review Officer, Resources 

and Training Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, 6116 Executive Boulevard, Room 

8103, Bethesda, MD 20892, (301) 594–1279, 

meekert@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: December 28, 2010. 

Anna P. Snouffer, 

Deputy Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–33287 Filed 1–4–11; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; 

Therapeutic Strategies for Cancer. 

Date: February 2–4, 2011. 

Time: 3 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hilton Washington/Rockville, 1750 

Rockville Pike, Rockville, MD 20852. 

Contact Person: Majed M. Hamawy, 

M.B.A., PhD, Scientific Review Officer, 

Research Programs Review Branch, Division 

of Extramural Activities, National Cancer 

Institute, NIH, 6116 Executive Boulevard, 

Room 8135, Bethesda, MD 20852, 301–594– 

5659, mh101v@nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; K99 and 

T32 Review. 

Date: February 22, 2011. 

Time: 5 p.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hilton Alexandria Old Town, 1767 

King Street, Alexandria, VA 22314. 

Contact Person: Sergei Radaev, PhD, 

Scientific Review Officer, Resources and 

Training Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 6116 Executive Boulevard, 

Room 8117, Bethesda, MD 20892, 301–435– 

5655, sradaev@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: December 28, 2010. 

Anna P. Snouffer, 

Deputy Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–33285 Filed 1–4–11; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HOUSING AND 

URBAN DEVELOPMENT 

[Docket No. FR–5415–C–20] 

Notice of Funding Availability (NOFA) 

for HUD’s Fiscal Year 2010; Resident 

Opportunity and Self-Sufficiency 

(ROSS)—Service Coordinators 

Program; Extension of Application Due 

Date 

AGENCY: Office of the Assistant 

Secretary for Public and Indian 

Housing, HUD. 

ACTION: Notice of Funding Availability 

for HUD’s Fiscal Year (FY) 2010 

Resident Opportunity and SelfSufficiency (ROSS) Service 

Coordinators Program; Extension of 

Application Due Date. 


jlentini on DSKJ8SOYB1PROD with NOTICES